Abstract. The 
The metabolism of vitamin D is essential in the control of bone and mineral metabolism (Haussler & McCain 1977a,b Mundy et al. 1976 ), which tends to increase serum calcium and phos¬ phate concentrations, and this might explain why our patient developed hypercalcaemia at the second incidence. An alternative explanation could be increased bioavailabilty of dihydrotachysterol when the thyroxine dosage was increased. Altered metabolism of drugs in thyroid disorders has been discussed by Eichelbaum (1976) .
In patients with normal parathyroids and normal renal function, the increased bone résorption accompanying hyperthyroidism tends to increase serum calcium, which causes a decrease in parathy¬ roid hormone secretion (Mosekilde & Christensen 1977) . This homeostatic mechanism suppresses the renal 1 -hydroxylase enzyme and the serum concen¬ tration of 1,25-dihydroxycholecalciferol is reduced (Bouillon et al. 1980 
